Assessing cholinergic innervation in Parkinson’s disease using the PET imaging marker [18F]Fluoroethoxybenzovesamicol
Objective: To validate [18F]Fluoroethoxybenzovesamicol ([18F]FEOBV) imaging in healthy volunteers by dynamic scanning. The secondary objective of this study was to evaluate the differences in [18F]FEOBV binding…Non-motor symptom burden is associated with thalamic atrophy in Parkinson’s disease
Objective: To investigate whether non-motor symptoms burden is associated with cortical and subcortical morphological changes in PD patients. Background: Non-motor symptoms are common aspects of…Pilot evaluation of pseudoelastic orthoses for supporting motor control in children with secondary dystonia and dyskinesia
Objective: The study reports preliminary observations on the use of orthotic devices with nonlinear spring properties prescribed with the aim to stabilise posture and improve…Disparities in Access to DBS Surgery Based on Demographics of Patients with PD Admitted for DBS Surgery in the United States from 2003 to 2013
Objective: To better understand current demographics of DBS use and identify non-medical barriers to its utilization. Background: Parkinson’s Disease (PD) has seen increasingly more sophisticated…Movement Disorders in Demyelinating Diseases: a retrospective review from a tertiary academic center.
Objective: To review the prevalence of movement disorders (MD) in patients with demyelinating diseases (DD) treated at a tertiary academic center and to characterize their therapeutic response…Body mass index, change in body mass index and risk of Parkinson`s disease
Objective: Our aim is to show the association between BMI and risk of PD and to evaluate how change in BMI is associated with occurrence…Safinamide improves both motor and non-motor symptoms in fluctuating Parkinson’s Disease patients.
Objective: To investigate the efficacy of safinamide, compared to placebo, as add-on therapy to stable doses of levodopa, on both motor and non-motor symptoms in…Riding the puzzle: deep brain stimulation and the non-motor symptoms in Parkinson’s disease
Objective: To better understand the benefits of DBS in non-motor symptoms. Background: Parkinson's disease(PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons,…Parkinson Disease-Associated Polyneuropathy: A Biomarker of Disease Severity?
Objective: Objective: We sought to examine the association between Parkinson disease (PD) associated polyneuropathy (PD-PNP) and levodopa dose, age, and disease duration in a cross-sectional,…An association between impulse control disorders and dopamine agonists in Japanese patients with Parkinson’s disease.
Objective: To evaluate an association between impulse control disorders (ICDs) and dopamine agonists (DA) therapy in Japanese patients with Parkinson’s disease (PD). Background: ICDs such…
- « Previous Page
- 1
- …
- 86
- 87
- 88
- 89
- 90
- …
- 155
- Next Page »